SRF Ltd (SRF) Q3FY26 Management Mirror - Dec-2025 Qtr
Chemicals Business (Specialty & Fluorochemicals)
Near-Term Outlook: Management anticipates a strong finish to Mar'26 (Q4), expecting "significantly better" performance than Q3 due to deferred order execution and signs of agrochemical revival. This refines the Sep'25 view where management raised the annual growth outlook to surpass the previous 20% target.
Refrigerant Gases: Domestic demand is projected to uptick with the summer season, helping maximize production quotas.
Pricing: Expectations remain consistent across quarters; management currently sees stable/firm prices for R-32, contingent on Chinese pricing discipline. This aligns with the Jun'25 guidance forecasting stable to higher HFC pricing trends for FY26.
Agrochemicals: The outlook has shifted from cautious optimism regarding new Active Ingredients (AIs) traction in Jun'25 to explicit signals of revival and a strong pipeline in Dec'25.
Pharma: Aims to increase segment contribution from ~10% to at least 20% over time.
3 more themes on the ELITE plan.